FOLR1 and neoplasm: This restriction is lost in the setting of malignant transformation as FOLR1 becomes overexpressed in various solid tumors such as lung, breast, ovarian, and gastric cancers and is associated with more aggressive tumor behavior and poor response to chemoradiation (14–17).